Necroptosis-Related Prognostic Model for Pancreatic Carcinoma Reveals Its Invasion and Metastasis Potential through Hybrid EMT and Immune Escape

Necroptosis, pro-inflammatory programmed necrosis, has been reported to exert momentous roles in pancreatic cancer (PC). Herein, the objective of this study is to construct a necroptosis-related prognostic model for detecting pancreatic cancer. In this study, the intersection between necroptosis-related genes and differentially expressed genes (DEGs) of pancreatic ductal adenocarcinoma (PDAC) was obtained based on GeneCards database, GEO database (GSE28735 and GSE15471), and verified using The Cancer Genome Atlas (TCGA). Next, a prognostic model with Cox and LASSO regression analysis, and divided the patients into high-risk and low-risk groups. Subsequently, the Kaplan–Meier (KM) survival curve and the receiver operating characteristic (ROC) curves were generated to assess the predictive ability of overall survival (OS) of PC patients. Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were performed to predict the potential biofunction and possible mechanical pathways. The EMTome database and an immune analysis were applied to further explore underlying mechanism. Finally, clinical samples of PDAC patients were utilized to verify the expression of model genes via immunohistochemistry (IHC), and the normal human pancreatic ductal cell line, hTERT-HPNE as well as human pancreatic ductal carcinoma cell lines, PANC-1 and PL45, were used to identify the levels of model genes by Western blot (WB) and immunofluorescence (IF) in vitro. The results showed that 13 necroptosis-related DEGs (NRDEGs) were screened based on GEO database, and finally four of five prognostic genes, including KRT7, KRT19, IGF2BP3, CXCL5, were further identified by TCGA to successfully construct a prognostic model. Univariate and multivariate Cox analysis ultimately confirmed that this prognostic model has independent prognostic significance, KM curve suggested that the OS of low-risk group was longer than high-risk group, and the area under receiver (AUC) of ROC for 1, 3, 5 years was 0.733, 0.749 and 0.667, respectively. A GO analysis illustrated that model genes may participate in cell–cell junction, cadherin binding, cell adhesion molecule binding, and neutrophil migration and chemotaxis, while KEGG showed involvement in PI3K-Akt signaling pathway, ECMreceptor interaction, IL-17 signaling pathway, TNF signaling pathway, etc. Moreover, our results showed KRT7 and KRT19 were closely related to EMT markers, and EMTome database manifested that KRT7 and KRT19 are highly expressed in both primary and metastatic pancreatic cancer, declaring that model genes promoted invasion and metastasis potential through EMT. In addition, four model genes were positively correlated with Th2, which has been reported to take part in promoting immune escape, while model genes except CXCL5 were negatively correlated with TFH cells, indicating that model genes may participate in immunity. Additionally, IHC results showed that model genes were higher expressed in PC tissues than that in adjacent tumor tissues, and WB and IF also suggested that model genes were more highly expressed in PANC-1 and PL45 than in hTERT-HPNE. Tracing of a necroptosis-related prognostic model for pancreatic carcinoma reveals its invasion and metastasis potential through EMT and immunity. The construction of this model and the possible mechanism of necroptosis in PDAC was preliminarily explored to provide reliable new biomarkers for the early diagnosis, treatment, and prognosis for pancreatic cancer patients.

[1]  S. Kang,et al.  COX-2 Acts as a Key Mediator of Trifluoperazine-induced Cell Death in U87MG Glioma Cells , 2022, Anticancer Research.

[2]  Qi Zhao,et al.  IMB5036 inhibits human pancreatic cancer growth primarily through activating necroptosis , 2021, Basic & clinical pharmacology & toxicology.

[3]  Jinming Yu,et al.  ZBP1-MLKL necroptotic signaling potentiates radiation-induced antitumor immunity via intratumoral STING pathway activation , 2021, Science advances.

[4]  M. Villanueva.  Putting a PIN in pancreatic cancer , 2021, Nature reviews. Drug discovery.

[5]  G. Kroemer,et al.  Cell death in pancreatic cancer: from pathogenesis to therapy , 2021, Nature Reviews Gastroenterology & Hepatology.

[6]  Zhenyu Liao,et al.  Follicular Helper T Cells Remodel the Immune Microenvironment of Pancreatic Cancer via Secreting CXCL13 and IL-21 , 2021, Cancers.

[7]  Hongsheng Wang,et al.  N6-Methyladenosine Regulates mRNA Stability and Translation Efficiency of KRT7 to Promote Breast Cancer Lung Metastasis , 2021, Cancer Research.

[8]  Jeffrey T. Chang,et al.  EMTome: a resource for pan-cancer analysis of epithelial-mesenchymal transition genes and signatures , 2020, British Journal of Cancer.

[9]  Minoru Kanehisa,et al.  KEGG: integrating viruses and cellular organisms , 2020, Nucleic Acids Res..

[10]  Wei Li,et al.  CXCL5 promotes gastric cancer metastasis by inducing epithelial-mesenchymal transition and activating neutrophils , 2020, Oncogenesis.

[11]  T. Ohtsuka,et al.  Necroptosis in pancreatic cancer promotes cancer cell migration and invasion by release of CXCL5 , 2020, PloS one.

[12]  Liangjing Wang,et al.  Fusobacterium nucleatum promotes colorectal cancer metastasis by modulating KRT7-AS/KRT7 , 2020, Gut microbes.

[13]  Minghui Zhang,et al.  An Immune-Related Signature Predicts Survival in Patients With Lung Adenocarcinoma , 2019, Front. Oncol..

[14]  G. Beatty,et al.  Cellular determinants and therapeutic implications of inflammation in pancreatic cancer. , 2019, Pharmacology & therapeutics.

[15]  J. Iovanna,et al.  Emerging epigenomic landscapes of pancreatic cancer in the era of precision medicine , 2019, Nature Communications.

[16]  S. Offermanns,et al.  TAK1 regulates endothelial cell necroptosis and tumor metastasis , 2019, Cell Death & Differentiation.

[17]  T. Nomura,et al.  The epithelial immune microenvironment (EIME) in atopic dermatitis and psoriasis , 2018, Nature Immunology.

[18]  Chengyu Liu,et al.  Necroptosis of tumor cells leads to tumor necrosis and promotes tumor metastasis , 2018, Cell Research.

[19]  E. Furth,et al.  EMT Subtype Influences Epithelial Plasticity and Mode of Cell Migration. , 2018, Developmental cell.

[20]  Yan Zhou,et al.  Netrin G1 promotes pancreatic tumorigenesis through cancer associated fibroblast driven nutritional support and immunosuppression , 2018, bioRxiv.

[21]  T. Voet,et al.  Identification of the tumour transition states occurring during EMT , 2018, Nature.

[22]  Stefan Hüttelmaier,et al.  Recognition of RNA N6-methyladenosine by IGF2BP Proteins Enhances mRNA Stability and Translation , 2018, Nature Cell Biology.

[23]  G. Kroemer,et al.  Inhibition of Aurora Kinase A Induces Necroptosis in Pancreatic Carcinoma. , 2017, Gastroenterology.

[24]  Q. Cheng,et al.  CXCL5 promotes the proliferation and migration of glioma cells in autocrine- and paracrine-dependent manners. , 2016, Oncology reports.

[25]  L. Wood,et al.  Pancreatic cancer , 2016, The Lancet.

[26]  B. Blencowe,et al.  IGF2BP3 Modulates the Interaction of Invasion-Associated Transcripts with RISC. , 2016, Cell reports.

[27]  M. Bertrand,et al.  Vaccination with Necroptotic Cancer Cells Induces Efficient Anti-tumor Immunity. , 2016, Cell reports.

[28]  Sarah I. Alothman,et al.  The Necrosome Promotes Pancreas Oncogenesis via CXCL1 and Mincle Induced Immune Suppression , 2016, Nature.

[29]  J. Abraham,et al.  Long non-coding antisense RNA KRT7-AS is activated in gastric cancers and supports cancer cell progression by increasing KRT7 expression , 2015, Oncogene.

[30]  K. Tomczak,et al.  The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge , 2015, Contemporary oncology.

[31]  G. Beatty,et al.  Immune Escape Mechanisms as a Guide for Cancer Immunotherapy , 2014, Clinical Cancer Research.

[32]  R. Gascoyne,et al.  Clinical Significance of Genetic Aberrations in Diffuse Large B Cell Lymphoma , 2014 .

[33]  Jack A. Taylor,et al.  Keratin 19: a key role player in the invasion of human hepatocellular carcinomas , 2013, Gut.

[34]  E. Duda,et al.  Importance of reverse signaling of the TNF superfamily in immune regulation , 2013, Expert review of clinical immunology.

[35]  Justin Guinney,et al.  GSVA: gene set variation analysis for microarray and RNA-Seq data , 2013, BMC Bioinformatics.

[36]  Sean R. Davis,et al.  NCBI GEO: archive for functional genomics data sets—update , 2012, Nucleic Acids Res..

[37]  Xiaodong Wang,et al.  Mixed Lineage Kinase Domain-like Protein Mediates Necrosis Signaling Downstream of RIP3 Kinase , 2012, Cell.

[38]  M. P. Protti,et al.  Cross-talk within the tumor microenvironment mediates Th2-type inflammation in pancreatic cancer , 2012, Oncoimmunology.

[39]  Hao-dong Xu,et al.  The use of insulin like-growth factor II messenger RNA binding protein-3 in diagnostic pathology. , 2011, Human pathology.

[40]  Tsviya Olender,et al.  GeneCards Version 3: the human gene integrator , 2010, Database J. Biol. Databases Curation.

[41]  D. Huntsman,et al.  Insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) overexpression in pancreatic ductal adenocarcinoma correlates with poor survival , 2010, BMC Cancer.

[42]  A. Masamune,et al.  Roles of pancreatic stellate cells in pancreatic inflammation and fibrosis. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[43]  Na Zhang,et al.  RIP3, an Energy Metabolism Regulator That Switches TNF-Induced Cell Death from Apoptosis to Necrosis , 2009, Science.

[44]  Tao Wang,et al.  Receptor Interacting Protein Kinase-3 Determines Cellular Necrotic Response to TNF-α , 2009, Cell.

[45]  D. Huntsman,et al.  IGF2BP3 (IMP3) expression is a marker of unfavorable prognosis in ovarian carcinoma of clear cell subtype , 2009, Modern Pathology.

[46]  E. Birgitte Lane,et al.  New consensus nomenclature for mammalian keratins , 2006, The Journal of cell biology.

[47]  F. Nielsen,et al.  RNA‐binding IMPs promote cell adhesion and invadopodia formation , 2006, The EMBO journal.

[48]  Alexei Degterev,et al.  Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury , 2005, Nature chemical biology.

[49]  P. Kidd.  Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. , 2003, Alternative medicine review : a journal of clinical therapeutic.

[50]  S. Romagnani,et al.  T-cell subsets (Th1 versus Th2). , 2000, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[51]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.